Trial Profile
Phase II study in combination with Carboplatin and TS-1 [S 1] for Cancer of unknown primary
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 May 2017
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Cancer
- Focus Therapeutic Use
- 01 Aug 2008 New trial record.